Trastuzumab emtansine (T-DM1) in patients with HER2-positive metastatic breast cancer and brain metastases: exploratory final analysis of cohort 1 from KAMILLA, a single-arm phase III b clinical trial☆ - Montemurro, F; Delaloge, S; Barrios, C H (Ann Oncol, 2020)